title: Evaluation of clonidine suppression and various provocation tests in the diagnosis of pheochromocytoma.
abstract: Recent investigations have shown that the widely used clonidine suppression test is sometimes fallible for the diagnosis of pheochromocytoma. A comparative assessment was made of the following suppression and provocation tests, the clonidine suppression test, and the glucagon, metoclopramide, and naloxone provocation tests. The assessment was performed in 6 patients with pheochromocytoma and in 19 patients without pheochromocytoma who were initially suspected of harboring a tumor. BP response did not predict the presence of pheochromocytoma in any test. Plasma norepinephrine (NE) concentrations determined at 120 and 180 min after oral 150 micrograms of clonidine gave false negative results in 2 of the 5 patients with pheochromocytoma tested. Both plasma NE and epinephrine (E) concentrations were measured before and sequentially after each provocative agent. Neither NE nor E responded to 1 mg of glucagon iv in 2 of the 4 patients with pheochromocytoma tested. Determination of the peak level, peak increment, and % peak increment of NE and E following 10 mg of naloxone iv did not distinguish the two groups. The % peak increments of both NE and E in all 4 patients with pheochromocytoma given 5 mg of metoclopramide iv exceeded the mean + 3 SD values of the patients without pheochromocytoma (25 + 28% for NE, and 25 + 42% for E). These results suggested that, when performed with judicious patient selection (ambiguous plasma or urinary catecholamine levels), the measurement of plasma catecholamines in response to metoclopramide can be a useful adjunctive tool in the diagnosis of pheochromocytoma.
authors.affiliation: Second Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Koshida
authors.forename: I
authors.initials: I
authors.lastname: Miyamori
authors.forename: R
authors.initials: R
authors.lastname: Soma
authors.forename: T
authors.initials: T
authors.lastname: Matsubara
authors.forename: S
authors.initials: S
authors.lastname: Okamoto
authors.forename: M
authors.initials: M
authors.lastname: Ikeda
authors.forename: R
authors.initials: R
authors.lastname: Takeda
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000175:diagnosis* / Q000503:physiopathology; D000328:Adult; D000368:Aged; D001794:Blood Pressure; D003000:Clonidine; D004837:Epinephrine / Q000097:blood; D005260:Female; D005934:Glucagon; D006801:Humans; D007700:Kinetics; D008297:Male; D008787:Metoclopramide; D008875:Middle Aged; D009270:Naloxone; D009638:Norepinephrine / Q000097:blood; D010673:Pheochromocytoma / Q000175:diagnosis* / Q000503:physiopathology
chemical_list: D009270:Naloxone; D005934:Glucagon; D008787:Metoclopramide; D003000:Clonidine; D009638:Norepinephrine; D004837:Epinephrine